€91.97
0.70% yesterday
Paris, May 29, 05:39 pm CET
ISIN
FR0000120578
Symbol
SAN
Sector
Industry

Sanofi Stock price

€91.97
-2.26 2.40% 1M
-0.12 0.13% 6M
-1.77 1.89% YTD
+4.26 4.86% 1Y
-8.45 8.41% 3Y
+4.95 5.69% 5Y
+3.34 3.77% 10Y
Paris, Closing price Thu, May 29 2025
-0.65 0.70%
ISIN
FR0000120578
Symbol
SAN
Sector
Industry

Key metrics

Market capitalization €112.95b
Enterprise Value €126.01b
P/E (TTM) P/E ratio 8.96
EV/Sales (TTM) EV/Sales 1.38
P/S ratio (TTM) P/S ratio 1.23
P/B ratio (TTM) P/B ratio 1.56
Dividend yield 4.26%
Last dividend (FY24) €3.92
Revenue (TTM) Revenue €91.55b
EBIT (operating result TTM) EBIT €20.52b
Cash position €7.99b
EPS (TTM) EPS €10.27
P/E forward 13.85
P/S forward 2.47
EV/Sales forward 2.75
Show more

Is Sanofi a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,782 stocks worldwide.

Sanofi Stock Analysis

Unlock Scores for Free

Analyst Opinions

26 Analysts have issued a Sanofi forecast:

21x Buy
81%
5x Hold
19%

Analyst Opinions

26 Analysts have issued a Sanofi forecast:

Buy
81%
Hold
19%

Financial data from Sanofi

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Mar '25
+/-
%
91,547 91,547
-
100%
- Direct Costs 27,028 27,028
-
30%
64,519 64,519
-
70%
- Selling and Administrative Expenses 19,346 19,346
-
21%
- Research and Development Expense 14,477 14,477
-
16%
24,212 24,212
-
26%
- Depreciation and Amortization 3,688 3,688
-
4%
EBIT (Operating Income) EBIT 20,524 20,524
-
22%
Net Profit 12,677 12,677
-
14%

In millions EUR.

Don't miss a Thing! We will send you all news about Sanofi directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Sanofi Stock News

AD HOC NEWS
about one month ago
Der Arzneimittelhersteller Sanofi FR0000120578 ist unerwartet stark in das Jahr gestartet.
AD HOC NEWS
about one month ago
Für den Arzneimittelhersteller Sanofi FR0000120578 hat das Jahr unerwartet stark begonnen.
AD HOC NEWS
2 months ago
Die US-Investmentbank Goldman Sachs hat die Bewertung der Aktien des Pharmakonzerns Sanofi FR0000120578 beim Kursziel von 120 Euro mit "Neutral" aufgenommen.
More Sanofi News

Company Profile

Sanofi engages in the research, production, and distribution of pharmaceutical products. It operates through the following business segments: Pharmaceuticals, Consumer Healthcare, and Vaccines. The Pharmaceuticals segment comprises the commercial operations of the following global franchises: specialty care, diabetes and cardiovascular, established prescription products and generics, and research, development, and production activities. The Consumer Healthcare segment includes the commercial operations for its Consumer Healthcare products. The Vaccines segment consists commercial operations of Sanofi Pasteur. The company was founded in 1973 and is headquartered in Paris, France.

Head office France
CEO Paul Hudson
Employees 82,878
Founded 1994
Website www.sanofi.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today